Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture

Neuroscience. 2002;110(2):213-25. doi: 10.1016/s0306-4522(01)00574-7.

Abstract

The Ca(2+)/calmodulin-dependent protein phosphatase, calcineurin, modulates a number of key Ca(2+) signaling pathways in neurons, and has been implicated in Ca(2+)-dependent negative feedback inactivation of N-methyl-D-aspartate receptors and voltage-sensitive Ca(2+) channels. In contrast, we report here that three mechanistically disparate calcineurin inhibitors, FK-506, cyclosporin A, and the calcineurin autoinhibitory peptide, inhibited high-voltage-activated Ca(2+) channel currents by up to 40% in cultured hippocampal neurons, suggesting that calcineurin acts to enhance Ca(2+) currents. This effect occurred with Ba(2+) or Ca(2+) as charge carrier, and with or without intracellular Ca(2+) buffered by EGTA. Ca(2+)-dependent inactivation of Ca(2+) channels was not affected by FK-506. The immunosuppressant, rapamycin, and the protein phosphatase 1/2A inhibitor, okadaic acid, did not decrease Ca(2+) channel current, showing specificity for effects on calcineurin. Blockade of L-type Ca(2+) channels with nimodipine fully negated the effect of FK-506 on Ca(2+) channel current, while blockade of N-, and P-/Q-type Ca(2+) channels enhanced FK-506-mediated inhibition of the remaining L-type-enriched current. FK-506 also inhibited substantially more Ca(2+) channel current in 4-week-old vs. 2-week-old cultures, an effect paralleled by an increase in calcineurin A mRNA levels. These studies provide the first evidence that calcineurin selectively enhances L-type Ca(2+) channel activity in neurons. Moreover, this action appears to be increased concomitantly with the well-characterized increase in L-type Ca(2+) channel availability in hippocampal neurons with age-in-culture.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aging / metabolism*
  • Animals
  • Apoptosis Regulatory Proteins
  • Calcineurin / genetics
  • Calcineurin / metabolism*
  • Calcineurin Inhibitors
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / metabolism*
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology*
  • Carrier Proteins / pharmacology
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology*
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Cyclosporine / pharmacology
  • Female
  • Fetus
  • Hippocampus / drug effects
  • Hippocampus / growth & development*
  • Hippocampus / metabolism*
  • Immunosuppressive Agents / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Phosphoprotein Phosphatases / metabolism
  • Pregnancy
  • Protein Phosphatase 1
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Tacrolimus / pharmacology
  • Tacrolimus Binding Protein 1A / pharmacology

Substances

  • Apoptosis Regulatory Proteins
  • Cabin1 protein, rat
  • Calcineurin Inhibitors
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Carrier Proteins
  • Chelating Agents
  • Immunosuppressive Agents
  • RNA, Messenger
  • Cyclosporine
  • Calcineurin
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
  • Tacrolimus Binding Protein 1A
  • Tacrolimus